Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00125775
What this trial is testing

Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?

Who this might be right for
Peritoneal DialysisRenal Disease, End-Stage
Chinese University of Hong Kong 130
Not applicableStudy completedNCT05633836
What this trial is testing

MicroFluO: FLUorescence-guided Surgery for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Assistance Publique - Hôpitaux de Paris 3
Testing effectiveness (Phase 2)Ended earlyNCT02059265
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT01768936
What this trial is testing

Procalcitonin Ratio's Impact on the Decision Upon On-demand Relaparotomy in Septic Peritonitis

Who this might be right for
Secondary Peritonitis After Intestinal Perforation
CHIR-Net 234
Not applicableUnknownNCT01062334
What this trial is testing

Peritoneal Microdialysis in Patients Undergoing Low Anterior Resection for Rectum Cancer

Who this might be right for
Cancer
Odense University Hospital 150
Not applicableUnknownNCT03845530
What this trial is testing

The Inflammatory Burden in Hemodialysis vs. Peritoneal Dialysis Patients: the Role of Alpha-defensin

Who this might be right for
Kidney FailureInflammation
Hillel Yaffe Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT00436644
What this trial is testing

Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 18
Early research (Phase 1)Study completedNCT00523432
What this trial is testing

A Phase I Study of CCI-779 (Temsirolimus) in Combination With Topotecan in Patients With Gynecologic Malignancies

Who this might be right for
Genital Neoplasms, Female
University of Chicago 15
Testing effectiveness (Phase 2)UnknownNCT04155671
What this trial is testing

POF Versus FOLFOX Plus IP Paclitaxel in AGC

Who this might be right for
Gastric Cancer
Fujian Cancer Hospital 260
Early research (Phase 1)Ended earlyNCT02452775
What this trial is testing

Autologous OC-L Vaccine and Ovarian Cancer

Who this might be right for
Primary Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 3
Not applicableEnded earlyNCT00801775
What this trial is testing

Improved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry

Who this might be right for
Peritoneal Dialysis-associated Peritonitis
University Hospital, Basel, Switzerland 8
Not applicableNot Yet RecruitingNCT07690332
What this trial is testing

A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
NING LI-GYN 400
Large-scale testing (Phase 3)Study completedNCT02311907
What this trial is testing

Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityNeuropathyNeurotoxicity Syndrome+13 more
Alliance for Clinical Trials in Oncology 195
Testing effectiveness (Phase 2)Study completedNCT00501644
What this trial is testing

Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)Study completedNCT00059787
What this trial is testing

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more
National Cancer Institute (NCI) 56
Not applicableStudy completedNCT03517852
What this trial is testing

Intravital Microscopy (IVM) in Patients With Peritoneal Carcinomatosis (PC)

Who this might be right for
Peritoneal Carcinomatosis
Mayo Clinic 30
Early research (Phase 1)UnknownNCT05195125
What this trial is testing

Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients

Who this might be right for
End Stage Liver DIseaseObesityAcute Kidney Injury
University of Colorado, Denver 15
Testing effectiveness (Phase 2)Study completedNCT00391118
What this trial is testing

Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")

Who this might be right for
Ovarian CancerFallopian Tube NeoplasmsPeritoneal Neoplasm
Eli Lilly and Company 153
Not applicableStudy completedNCT00433264
What this trial is testing

The Interrelation of the Vasculature, Endothelium, Bone Metabolism and Uremic Toxins in Peritoneal Dialysis

Who this might be right for
Chronic Kidney Disease
Universitaire Ziekenhuizen KU Leuven 62
Not applicableWithdrawnNCT02667925
What this trial is testing

Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin

Who this might be right for
Ovarian Cancer
Centre Jean Perrin
Next Page